Hakki M - Search Results

1

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT, Doi Y, Lewis JS. Hakki M, et al. Clin Infect Dis. 2019 May 30;68(12):2045-2052. doi: 10.1093/cid/ciy825. Clin Infect Dis. 2019. PMID: 30256922 Free PMC article.

2

Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Hakki M, Lewis JS 2nd. Hakki M, et al. Infection. 2018 Jun;46(3):431-434. doi: 10.1007/s15010-018-1125-5. Epub 2018 Feb 19. Infection. 2018. PMID: 29460229

3

Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Fontana L, Perlin DS, Zhao Y, Noble BN, Lewis JS, Strasfeld L, Hakki M. Fontana L, et al. Among authors: hakki m. Clin Infect Dis. 2020 Feb 14;70(5):723-730. doi: 10.1093/cid/ciz282. Clin Infect Dis. 2020. PMID: 30958538 Free PMC article.

4

Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre.

Bowen CD, Tallman GB, Hakki M, Lewis Ⅱ JS. Bowen CD, et al. Among authors: hakki m. Mycoses. 2019 Aug;62(8):665-672. doi: 10.1111/myc.12924. Epub 2019 May 23. Mycoses. 2019. PMID: 31050373

5

New Perspectives on Antimicrobial Agents: Isavuconazole.

Lewis JS 2nd, Wiederhold NP, Hakki M, Thompson GR 3rd. Lewis JS 2nd, et al. Among authors: hakki m. Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0017722. doi: 10.1128/aac.00177-22. Epub 2022 Aug 15. Antimicrob Agents Chemother. 2022. PMID: 35969068 Free PMC article. Review.

6

Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients.

Zhang L, Tan FC, Strasfeld L, Hakki M, Kirienko NV. Zhang L, et al. Among authors: hakki m. Front Cell Infect Microbiol. 2022 Jun 16;12:904602. doi: 10.3389/fcimb.2022.904602. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35782141 Free PMC article.

7

Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.

Perry DA, Hakki M. Perry DA, et al. Among authors: hakki m. Transpl Infect Dis. 2016 Oct;18(5):809-814. doi: 10.1111/tid.12591. Epub 2016 Sep 23. Transpl Infect Dis. 2016. PMID: 27502917

8

The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.

Hakki M, Rattray RM, Press RD. Hakki M, et al. J Clin Virol. 2015 Jul;68:1-5. doi: 10.1016/j.jcv.2015.04.012. Epub 2015 Apr 15. J Clin Virol. 2015. PMID: 26071326 Free PMC article.

9

Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation.

Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Hakki M, et al. Bone Marrow Transplant. 2007 Jun;39(11):687-93. doi: 10.1038/sj.bmt.1705653. Epub 2007 Apr 2. Bone Marrow Transplant. 2007. PMID: 17401395

10

UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.

Gregg K, Hakki M, Kaul DR. Gregg K, et al. Among authors: hakki m. Transpl Infect Dis. 2014 Apr;16(2):320-3. doi: 10.1111/tid.12200. Epub 2014 Mar 13. Transpl Infect Dis. 2014. PMID: 24621186 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters